OBI Pharma Cash Flow Quality Index

Latest as of June 2023: -1.19x

OBI Pharma cash flow quality index. OBI Pharma (4174) has a Cash Flow Quality Index of -1.19x as of June 2023. Operating cash flow of NT$-401.35 Million is below net income of NT$337.00 Million, suggesting accrual-heavy earnings not yet converted to cash. See OBI Pharma (4174) flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-1.19x

Operating CF / Net Income

Operating Cash Flow

NT$-401.35 Million

TWD

Net Income

NT$337.00 Million

TWD

Data as of

Jun 2023

Most recent filing

OBI Pharma Cash Flow Quality Index by Year (None–None)

OBI Pharma cash flow quality index by year from None to None. Year-by-year earnings quality comparison for OBI Pharma. For the full cash flow conversion analysis, see OBI Pharma cash flow conversion.

Year	Quality Index	Operating CF (TWD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.